This white paper aims to study, through the existing literature, the extent to which the different types of wearable technologies can enhance health and life expectancy, whether through the better health management they enable or the amount of data they provide to compute more accurate predictions for health and lifespan. Finally, this white paper analyzes the treatment of wearables in insurance contracts.
This article from The Actuary discusses results of an RGA study on the relationship between medical expenses and lifestyle factors that wearable devices can measure, such as physical activity, sleep, and heart rate. The conclusion: Lifestyle data can indeed help health insurers better assess risk, improve underwriting, and develop propositions that incentivize healthy lifestyles.
An initial review with a focus on epigenetic, medical tests and wearables.
The growing popularity of wearables presents insurers with an unparalleled opportunity to better assess risk – yet many carriers are not fully realizing the value of data from these devices.
In this edition of ReCent Medical News, Paul Edwards explains why health and fitness data captured through the use of wearables is potentially very meaningful for life insurance underwriting.
Brooks Tingle, president and chief executive officer, John Hancock Insurance, said the organization wants to promote engagement with insureds by partnering with a growing range of tech and service providers. Tingle spoke with AM BestTV at InsureTech Connect 2019, held in Las Vegas.
Wearable technology could dramatically change the way life carriers do business and interact with their customers. See what some insurers are already doing with wearables.
The cutting edge of the insurance industry involves adjusting premiums and policies based on new forms of surveillance.
There’s not enough oversight for apps that track everything from people’s fitness routines to their menstrual cycles, bioethicists say.
Technological advances in biosensors and increasing amounts of heart rate data from wearable devices and electronic health records are leading to the development of more sophisticated underwriting algorithms. This data, when coupled with robust epidemiological evidence about the prognostic value of heart rate, may improve insurer understanding of cardiovascular risk and ultimately allow underwriters to better predict morbidity and mortality risk.